肾移植中的LECT2淀粉样变性:5例报告
本文报告5例接受供体源性LECT2淀粉样变性肾脏的受者,淀粉样沉积在方案活检或怀疑排斥时发现,累及肾实质不足10%,以间质和血管沉积为主。随访至8年,移植肾功能未受损,沉积持续存在。结论认为局限且局灶的LECT2淀粉样沉积肾脏不必自动弃用。
要点
- 供肾LECT2淀粉样沉积局限(<10%肾实质)时移植肾功能可不受损。
- 沉积以间质和血管为主,可持续存在长达8年随访。
- 此类肾脏不必仅因LECT2淀粉样沉积而自动弃用。
核心结论
- 局限且局灶的LECT2淀粉样沉积肾脏若其他方面适合移植,不必自动弃用。
研究设计与样本
- 病例系列报告5例接受供体源性LECT2淀粉样变性肾脏的受者。
主要发现
- 5例均在方案活检或怀疑排斥评估中发现LECT2淀粉样变性。
- 肾实质受累不足10%,以间质和血管沉积为主。
- 移植肾功能未受损,淀粉样沉积持续至8年随访。
关键数值与推荐
- 肾实质受累<10%,以间质和血管沉积为主。
- 随访至8年,移植肾功能未受损。
临床怎么用
- 对局限且局灶的供肾LECT2淀粉样沉积,可考虑移植而非自动弃用。
局限性
- 样本量小(5例),为病例系列报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Leukocyte chemotactic factor 2 (LECT2) amyloidosis is a recently recognized entity that often affects the kidneys. Little information is available regarding kidney transplant outcomes in patients with LECT2 amyloidosis or who received kidney allografts containing LECT2 amyloid. We present clinical findings and allograft outcomes of 5 patients who received kidneys with donor-derived LECT2 amyloidosis. In all 5, LECT2 amyloidosis was discovered during protocol biopsies or in evaluation of suspected rejection. Less than 10% of kidney parenchyma was involved, with mostly interstitial and vascular deposits. Allograft function was not impaired and the amyloid deposits persisted for up to 8 years of follow-up. We conclude that kidneys with limited and localized LECT2 amyloid deposits that are otherwise suitable for transplantation need not be automatically discarded.
引用
- Mejia-Vilet JM, Cárdenas-Mastrascusa LR, Palacios-Cebreros EJ, et al. LECT2 Amyloidosis in Kidney Transplantation: A Report of 5 Cases. Am J Kidney Dis. 2019. PMID: 31155323. doi:10.1053/j.ajkd.2018.10.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。